TRACI LE: Open Payments
NPI 1225417124 · GARDEN GROVE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 18 payments from 10 companies in 2025. Trend: 2023 $1,230 · 2024 $882 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $123 |
| Abbott Laboratories | 5 | $113 |
| Lilly USA, LLC | 1 | $27 |
| Radius Health, Inc. | 1 | $23 |
| Ascendis Pharma Endocrinology Inc | 1 | $23 |
| Amphastar Pharmaceuticals, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Mannkind Corporation | 1 | $16 |
| CeQur Corporation | 1 | $14 |
Products named: FREESTYLE LIBRE 3, Ozempic, Wegovy, MOUNJARO, Yorvipath, JARDIANCE, GVOKE HYPOPEN, AFREZZA.
Industry payments across CA — which companies pay providers there.
